Utility of Different MR Modalities in Mild Cognitive Impairment and Its Use as a Predictor of Conversion to Probable Dementia

Academic Radiology

Volumn 15, Issue 9, 2008, Pages 1089-1098

  Fayed, Nicolas ^a   Dávila, Jorge ^a   Oliveros, Antonio ^a   Castillo, Julio ^a   Medrano, Jaime J ^a  

^a Division of Dermatology Quiron Hospital   (Spain)

Author keywords

Alzheimer's disease; dementia; diffusion; mild cognitive impairment; MRI; perfusion; proton magnetic resonance; single volume spectroscopy; spectroscopy

Indexed keywords

CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; AMNESIA; ANXIETY; ARTICLE; BLOOD TESTIS BARRIER; CEREBROVASCULAR DISEASE; CINGULATE GYRUS; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; DEPRESSION; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; LEWY BODY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIXED DEPRESSION AND DEMENTIA; NERVE DEGENERATION; NEUROPSYCHOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; STATISTICAL SIGNIFICANCE;

AGED; COGNITION DISORDERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PERFUSION IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 48649110697     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2008.04.008     Document Type: Article

References (51)

1. Grober E., Dickson D., Sliwinski M.J., et al. Memory and mental status correlates of modified Braak staging. Neurobiol Aging 20 (1999) 573-579
2. Petersen R.C., Smith G.E., Ivnik R.J., et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory impaired individuals. JAMA 273 (1995) 1274-1278
3. Smith G.E., Petersen R.C., Parisi J.E., et al. Definition, course, and outcome of mild cognitive impairment. Aging Neuropsiychol Cogn 3 (1996) 141-147
4. Portet F., Ousset P.J., Visser P.J., et al., MCI Working Group of the European Consortium on Alzheimer's Disease. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry 77 (2006) 714-718
5. Wolf H., Jelic V., Gertz H.J., et al. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand Suppl 179 (2003) 52-76
6. Krishnan S., Talley B.D., Slavin M.J., et al. Current status of functional MR imaging, perfusion-weighted imaging, and diffusion-tensor imaging in Alzheimer's disease diagnosis and research. Neuroimaging Clin N Am 15 (2005) 853-868
7. Valenzuela M.J., and Sachdev P. Magnetic resonance spectroscopy in AD. Neurology 56 (2001) 592-598
8. Modrego P.J., Fayed N., and Pina M.A. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatry 162 (2005) 667-675
9. Modrego P.J., Pina M.A., Fayed N., et al. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy. CNS Drugs 20 (2006) 867-877
10. Kantarci K., Weigand S.D., Petersen R.C., et al. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 28 (2007) 1330-1339
11. Kantarci K., Jack Jr. C.R., Xu Y.C., et al. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology 219 (2001) 101-107
12. Speck O., Chang L., DeSilva N.M., et al. Perfusion MRI of the human brain with dynamic susceptibility contrast: gradient-echo versus spin-echo techniques. J Magn Reson Imaging 12 (2000) 381-387
13. Harris G.J., Lewis R.F., Satlin A., et al. Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease. Am J Psychiatry 153 (1996) 721-724
14. Petersen R.C., Smith G.E., Waring S.C., et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 (1999) 303-308 correction 56:760.
15. McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
16. Spreen O., and Strauss E. Geriatric Depression Scale (GDS). In: Spreen O., and Strauss E. (Eds). A compendium of neuropsychological tests. 2nd ed. (1998), Oxford University Press, New York 612-616
17. Talairach J., and Tournoux P. Co-planar stereotaxic atlas of the human brain (1988), Thieme, New York
18. Belliveau J.W., Rosen B.R., Kantor H.L., et al. Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 14 (1990) 538-546
19. Harris G.J., Lewis R.F., Satlin A., et al. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. AJNR Am J Neuroradiol 19 (1998) 1727-1732
20. Harris G.J., Lewis R.F., Satlin A., et al. Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease. Am J Psychiatry 153 (1996) 721-724
21. Talbot P.R., Lloyd J.J., Snowden J.S., et al. Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med 21 (1994) 503-508
22. Reischies F.M., and Neu P. Comorbidity of mild cognitive disorder and depression-a neuropsychological analysis. Eur Arch Psychiatry Clin Neurosci 250 (2000) 186-193
23. Holmes C., Cairns N., Lantos P., et al. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174 (1999) 45-50
24. Evans M., and Mottram P. Diagnosis of depression in elderly patients. Adv Psychiatr Trends 6 (2000) 49-56
25. Gottfries C. Late life depression. Eur Arch Psychatry Clin Neurosci 251 (2001) 57-61
26. Tian J., Bucks R.S., Haworth J., et al. Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. J Neurol Neurosurg Psychiatry 74 (2003) 433-438
27. de Leon M.J., Golomb J., George A.E., et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol 14 (1993) 897-906
28. Du A.T., Schuff N., Amend D., et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 71 (2001) 441-447
29. Jack Jr. C.R., Petersen R.C., Xu Y.C., et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52 (1999) 1397-1403
30. Mega M.S. The entorhinal cortex in Alzheimer's disease. J Neurol Neurosurg Psychiatry 71 (2001) 431-432
31. Golomb J., de Leon M.J., Kluger A., et al. Hippocampal atrophy in normal aging. An association with recent memory impairment. Arch Neurol 50 (1993) 967-973
32. Nicolay K., Braun K.P., Graaf R.A., et al. Diffusion NMR spectroscopy. NMR Biomed 14 (2001) 94-111
33. Lu D., Margouleff C., Rubin E., et al. Temporal lobe epilepsy: correlation of proton magnetic resonance spectroscopy and 18F-fluorodeoxyglucose positron emission tomography. Magn Reson Med 37 (1997) 18-23
34. Mielke R., Schopphoff H.H., Kugel H., et al. Relation between 1H MR spectroscopic imaging and regional cerebral glucose metabolism in Alzheimer's disease. Int J Neurosci 107 (2001) 233-245
35. Frahm J., Krueger G., Merboldt K.D., et al. Dynamic NMR studies of perfusion and oxidative metabolism during focal brain activation. Adv Exp Med Biol 413 (1997) 195-203
36. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82 (1991) 239-259
37. Kantarci K., Jack Jr. C.R., Xu Y.C., et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 55 (2000) 210-217
38. Miller B.L., Moats R.A., Shonk T., et al. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 187 (1993) 433-437
39. Rai G.S., McConnell J.R., Waldman A., et al. Brain proton spectroscopy in dementia: an aid to clinical diagnosis. Lancet 353 (1999) 1063-1064
40. Shonk T.K., Moats R.A., Gifford P., et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 195 (1995) 65-72
41. Kantarci K., Xu Y., Shiung M.M., et al. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 14 (2002) 198-207
42. Kantarci K., Petersen R.C., Boeve B.F., et al. 1H MR spectroscopy in common dementias. Neurology 63 (2004) 1393-1398
43. Molina J.A., Garcia-Segura J.M., Benito-Leon J., et al. Proton magnetic resonance spectroscopy in dementia with Lewy bodies. Eur Neurol 48 (2002) 158-163
44. Tiraboschi P., Hansen L.A., Alford M., et al. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry 59 (2002) 946-951
45. Kantarci K, Weigand S, Petersen R, et al. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2006 Jul 20.
46. Martínez-Bisbal M.C., Arana E., Martí-Bonmatí L., Mollá E., and Celda B. Cognitive impairment: classification by 1H magnetic resonance spectroscopy. Eur J Neurol 11 (2004) 187-193
47. Ernst T., Chang L., Melchor R., et al. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 203 (1997) 829-836
48. Doraiswamy P.M., Barboriak D., Krishnan K.R.R., et al. Brain 1H-MR spectroscopy in subjects at risk for Alzheimer's disease. Neurobiol Aging 22 (2001) 338-339
49. Kantarci K., Petersen R.C., Boeve B.F., et al. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64 (2005) 902-904
50. Renshaw P.F., Levin J.M., Kaufman M.J., et al. Dynamic susceptibility contrast magnetic resonance imaging in neuropsychiatry: present utility and future promise. Eur Radiol 7 Suppl 5 (1997) 216-221
51. Perneczky R., Hartmann J., Grimmer T., et al. Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment. J Geriatr Psychiatry Neurol 20 (2007) 84-88